
Pediatric Cancer


March 28, 2024
Eflornithine for Adult and Pediatric Patients With High-Risk Neuroblastoma
The ASCO Post


Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.

August 13, 2024
FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.
Roswell Park Comprehensive Cancer Center

May 23, 2024
Clinical Trial Mounts Two-Pronged Attack Against Relapsed/Refractory Pediatric Sarcomas
Roswell Park Comprehensive Cancer Center

February 06, 2025
Bicistronic CAR T-Cell Therapy Demonstrates Clinical Activity in Relapsed or Refractory B-Cell ALL
The ASCO Post

Advertisement
Recommendations
Advertisement